NCT06998745 The Impact of MTM Model on the Efficacy and Safety of Anticoagulant Therapy in Postoperative Colorectal Cancer Patients
| NCT ID | NCT06998745 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sixth Affiliated Hospital, Sun Yat-sen University |
| Condition | Thrombosis, Venous |
| Study Type | INTERVENTIONAL |
| Enrollment | 327 participants |
| Start Date | 2025-05-01 |
| Primary Completion | 2027-12-30 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Anticoagulants are classified as high-risk medications, with their main adverse drug events (ADEs) being recurrent venous thromboembolism (VTE) and bleeding events.Postoperative colorectal cancer (CRC) patients exhibit a high probability of recurrent VTE and bleeding during anticoagulation therapy.The Medication Therapy Management (MTM) model will contribute to reducing ADEs associated with anticoagulants in CRC patients.
Eligibility Criteria
Inclusion Criteria: 1. Patients with histologically confirmed CRC and symptomatic or incidental VTE who received anticoagulant treatment. 2. CRC patients with VTE treated with an anticoagulant for at least 3 moths. Exclusion Criteria: 1.Participation in this study required active anticoagulant treatment. Apart from this, there were no specific exclusion criteria.